Fulgenzio, C.; Massari, M.; Traversa, G.; Da Cas, R.; Ferrante, G.; Aschbacher, R.; Moser, V.; Pagani, E.; Vestri, A.R.; Massidda, O.;
et al. Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study. Antibiotics 2021, 10, 451.
https://doi.org/10.3390/antibiotics10040451
AMA Style
Fulgenzio C, Massari M, Traversa G, Da Cas R, Ferrante G, Aschbacher R, Moser V, Pagani E, Vestri AR, Massidda O,
et al. Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study. Antibiotics. 2021; 10(4):451.
https://doi.org/10.3390/antibiotics10040451
Chicago/Turabian Style
Fulgenzio, Chiara, Marco Massari, Giuseppe Traversa, Roberto Da Cas, Gianluigi Ferrante, Richard Aschbacher, Verena Moser, Elisabetta Pagani, Anna Rita Vestri, Orietta Massidda,
and et al. 2021. "Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study" Antibiotics 10, no. 4: 451.
https://doi.org/10.3390/antibiotics10040451
APA Style
Fulgenzio, C., Massari, M., Traversa, G., Da Cas, R., Ferrante, G., Aschbacher, R., Moser, V., Pagani, E., Vestri, A. R., Massidda, O., & Kurotschka, P. K.
(2021). Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study. Antibiotics, 10(4), 451.
https://doi.org/10.3390/antibiotics10040451